Vext Science, Inc.
VEXT
CNSX
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 14.89% | 3.40% | -1.04% | -2.40% | 1.07% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 14.89% | 3.40% | -1.04% | -2.40% | 1.07% |
| Cost of Revenue | 15.00% | 18.60% | 27.10% | 46.75% | 85.75% |
| Gross Profit | 14.56% | -25.33% | -39.92% | -54.44% | -56.73% |
| SG&A Expenses | -18.61% | -17.66% | 89.87% | 86.31% | 38.62% |
| Depreciation & Amortization | 28.07% | 44.61% | 60.79% | 85.45% | 59.68% |
| Other Operating Expenses | 2,623.85% | 2,068.42% | 94.44% | 41.67% | -116.67% |
| Total Operating Expenses | 7.75% | 11.41% | 48.19% | 63.39% | 65.01% |
| Operating Income | 12.68% | -46.82% | -2,294.33% | -538.45% | -304.12% |
| Income Before Tax | -702.66% | -728.13% | -33.20% | -528.82% | -217.96% |
| Income Tax Expenses | 708.16% | 226.77% | 116.79% | 109.38% | 96.56% |
| Earnings from Continuing Operations | -867.91% | -610.06% | -250.02% | -194.69% | -122.98% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -867.91% | -610.06% | -250.02% | -194.69% | -122.98% |
| EBIT | 12.68% | -46.82% | -2,294.33% | -538.45% | -304.12% |
| EBITDA | 611.72% | 100.86% | -120.29% | -132.20% | -106.40% |
| EPS Basic | -695.96% | -599.47% | -180.49% | -160.62% | -115.89% |
| Normalized Basic EPS | -0.67% | -36.92% | -237.59% | -53,700.00% | -448.44% |
| EPS Diluted | -567.80% | -609.63% | -185.71% | -164.41% | -120.31% |
| Normalized Diluted EPS | -0.67% | -37.03% | -236.17% | -53,600.00% | -447.66% |
| Average Basic Shares Outstanding | 34.37% | 46.41% | 56.84% | 43.40% | 29.44% |
| Average Diluted Shares Outstanding | 34.50% | 46.56% | 57.42% | 43.04% | 29.05% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |